BLOG: Good news on Azasite

We interrupt our regularly scheduled blog post on the physician’s role in diagnosing dry eye to report some fantastic news: Merck has announced that it will continue to make and sell Azasite. If you take care of patients with dry eye, especially those who could be characterized as having some sort of meibomian gland disease (MGD) resulting in a dysfunctional tear syndrome, you were worried about this issue.

Full Story →